| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/27/2001 | US6207455 Lentiviral vectors |
| 03/27/2001 | US6207453 A replication-defective adeno-associated virus vector containing exogenous dna bound to a dna which codes for a rep protein; gene therapy |
| 03/27/2001 | US6207452 Antibody of the anti-proliferation domain of human Bcl-2 |
| 03/27/2001 | US6207450 Nucleic acid of defined nucleotide sequence which encodes fkhl7 protein; drug screening; primers; probes; gene therapy; antibodies; recombinant production |
| 03/27/2001 | US6207449 Nucleotide sequence of gene; hybridization probes for detection; drug screening for bactericides, bacteriostats and antibiotics |
| 03/27/2001 | US6207446 Selection of proteins using RNA-protein fusions |
| 03/27/2001 | US6207442 Plasmid construction by homologous recombination |
| 03/27/2001 | US6207440 Bacterial strain includes defined nucleotide sequence; fish aquariums; aquaculture |
| 03/27/2001 | US6207435 Method for producing nucleoside-5′-phosphate ester |
| 03/27/2001 | US6207433 Nucleotide and amino acid sequence of transferase enzyme; recombinant production; increased production of hemoprotein and heterologous proteins in culture |
| 03/27/2001 | US6207431 Glutamine:fructose-6-phosphate amidotransferase, its production and use |
| 03/27/2001 | US6207430 Recombinant production; discoloration inhibition in textiles and detergents; polymerization and depolymerization of lignin and derivatives; detoxification of soil; food processing of fruit juice |
| 03/27/2001 | US6207427 Method for producing optically active compound |
| 03/27/2001 | US6207426 Preparing preferentially propagating microorganism plasmid; obtain plasmid, insert preferential nucleotide sequences, evaluate propagation in cells |
| 03/27/2001 | US6207421 Nucleotide sequence determination; using deoxyribonucleic acids as templates to synthesize nucleotide sequences, stop synthesis of nucleotide sequences, analyzing the terminated nucleotide sequences |
| 03/27/2001 | US6207420 Nucleotide sequences for the transcription and translation of protein with preferential solubility; to prevent inclusion bodies in genetic engineering systems |
| 03/27/2001 | US6207419 Mutant serpin; for controlling blood coagulation, wound healing, tissue repair and prevent inflammation in humans |
| 03/27/2001 | US6207418 Production of a multimeric protein by cell fusion method |
| 03/27/2001 | US6207417 DNA encoding stem cell factor |
| 03/27/2001 | US6207416 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 03/27/2001 | US6207415 Preparing polypeptides in poultry embryonic tissues; propagating poultry tissues until tissue begins senescence, concentrating tissues, isolate non-senescent cells and propagate, recover polypeptides from tissues |
| 03/27/2001 | US6207414 Combining protein or peptide or polypetide with tyrosylprotein sulfotransferase and 3'-phosphoadenosine 5'-phosphosulfate to cause transfer of sulfate from phosphosulfate to tyrosine of the protein or peptide |
| 03/27/2001 | US6207413 Nucleotide sequence coding binding protein; for the diagnosis and treatment of endocrine defects |
| 03/27/2001 | US6207412 Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells |
| 03/27/2001 | US6207411 Bacteriocins |
| 03/27/2001 | US6207410 Nucleotide sequences that code proteins associated with ionic mobility; for the detection of pesticides |
| 03/27/2001 | US6207409 Culturing a recombinant cell that has been transformed with an expression vector having a regulatory sequence and a polynucleotide comprising a dna sequence which endcodes geranyl/geranylpyrophosphate of flavobacterium species |
| 03/27/2001 | US6207407 Identification of antibacterial agents |
| 03/27/2001 | US6207401 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
| 03/27/2001 | US6207394 Detection of vision defects; screening for genetic adjustment in cytochrome protein, detection of adjustment is indication vision defects |
| 03/27/2001 | US6207390 Incubating target with biotin in mixture, allow biotinylation, incubate heterogenous mix with solid support, incubate with target, monitor preferential binding of avidins |
| 03/27/2001 | US6207386 Compositions for the treatment and diagnosis of body weight disorders, including obesity |
| 03/27/2001 | US6207384 Systematic identification of essential genes by in vitro transposon mutagenesis |
| 03/27/2001 | US6207383 Adjusted nucleotide sequences associated with genetic disorder; for the diagnosis, treatment and prevention of arrhythmia |
| 03/27/2001 | US6207382 Production of lampbrush chromosome |
| 03/27/2001 | US6207381 Monitoring binding of probes to nucleotide sequences; incubate incubate nucleotide sequences with oligonucleotide probes, immobilize nucleotide sequence on support monitoring binding of oligonucleotide probes |
| 03/27/2001 | US6207377 Cloning preferential genes; isolate nucleotide sequences associated with expression, insert preferential nucleotide sequences, transform microorganism, isolated genetically engineered nucleotide sequences, transform and culture |
| 03/27/2001 | US6207374 Tuberous sclerosis 2 gene and uses thereof |
| 03/27/2001 | US6207373 Methods for determining nature of repeat units in DNA |
| 03/27/2001 | US6207372 Single-stranded oligonucleotide primers for the amplification of target nucleotide sequences; for the diagnosis of genetic and infectious disorders, sex determination, genetic linkage and forensic analysis |
| 03/27/2001 | US6207371 Classification of genetically engineered eucaryotic aggregations |
| 03/27/2001 | US6207367 Process for genetic mapping for plant identification and breeding purposes |
| 03/27/2001 | US6207217 Animal nutrition compositions |
| 03/27/2001 | US6207169 Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| 03/27/2001 | US6207168 Vaccine composition for herpes simplex virus and methods of using |
| 03/27/2001 | US6207166 Veterinary medicine |
| 03/27/2001 | US6207165 Polynucleotide formula against porcine reproductive and respiratory pathologies |
| 03/27/2001 | US6207162 AspS from Chlamydia trachomatis |
| 03/27/2001 | US6207160 aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies |
| 03/27/2001 | US6207158 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 03/27/2001 | US6207156 Specific antibodies and antibody fragments |
| 03/27/2001 | US6207154 Methods of treatment using antagonists of cytokine synthesis inhibitory factor |
| 03/27/2001 | US6207153 Antigen binding polypeptide |
| 03/27/2001 | US6207152 Anticancer agent |
| 03/27/2001 | US6207150 Variants of thymidine kinase, nucleic acids encoding them, and methods of using them |
| 03/27/2001 | US6207146 Gene expression in mammalian cells |
| 03/27/2001 | US6207144 Polypeptides with interleukin-16 activity, process for the preparation and use thereof |
| 03/27/2001 | CA2320575A1 Universal probes and methods for detection of nucleic acids |
| 03/27/2001 | CA2201098C Orphan receptor |
| 03/27/2001 | CA2161881C High lysine derivatives of alpha-hordothionin |
| 03/27/2001 | CA2135200C Canine coronavirus s gene and uses therefor |
| 03/27/2001 | CA2123107C Ubiquitin-specific proteases |
| 03/27/2001 | CA2076540C Recombinant antibodies specific for tnf-.alpha. |
| 03/27/2001 | CA2046916C Methods and compositions for treatment of cancer using oligonucleotides |
| 03/27/2001 | CA1341211C Mini-proinsulin, its preparation and use |
| 03/27/2001 | CA1341208C Proteins with factor viii activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them |
| 03/23/2001 | WO2001019976A2 Plant regulatory sequences for control of gene expression |
| 03/23/2001 | CA2388370A1 Plant regulatory sequences for control of gene expression |
| 03/23/2001 | CA2309372A1 Use of antibodies against the nef protein for decreasing the chemotaxis which is induced by retrovirus-infected astrocytes |
| 03/22/2001 | WO2001020336A2 SCREENING FOR α2δ-1 SUBUNIT BINDING LIGANDS |
| 03/22/2001 | WO2001020331A1 Substrates and screening methods for transport proteins |
| 03/22/2001 | WO2001020327A1 Spa in a screening method for modulators of glucokinase |
| 03/22/2001 | WO2001020039A2 Method of sequencing a nucleic acid |
| 03/22/2001 | WO2001020038A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 03/22/2001 | WO2001020035A2 Methods and compositions for linear isothermal amplification of polynucleotide sequences |
| 03/22/2001 | WO2001020034A2 Methods and compositions for the screening of cell cycle modulators |
| 03/22/2001 | WO2001020032A1 Method of analyzing intestinal flora and analytical apparatus |
| 03/22/2001 | WO2001020031A2 Polymorphisms in a klotho gene |
| 03/22/2001 | WO2001020030A2 Nucleotide sequences derived from genes coding for trimethylamine n-oxide reductase, uses thereof in particular for detecting bacteria |
| 03/22/2001 | WO2001020029A2 Genetic markers of toxicity, preparation and uses thereof |
| 03/22/2001 | WO2001020028A1 Single stranded oligonucleotides, probes, primers and method for detecting spirochetes |
| 03/22/2001 | WO2001020027A1 Methods and compositions for detecting pathological events |
| 03/22/2001 | WO2001020026A2 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 03/22/2001 | WO2001020025A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/22/2001 | WO2001020024A2 Method for determining nucleic and/or amino acid sequences |
| 03/22/2001 | WO2001020020A2 Method to identify herbicides, fungicides or plant growth regulators |
| 03/22/2001 | WO2001020018A2 Diagnosing and treating arthritic disorders |
| 03/22/2001 | WO2001020015A1 Reverse transfection method |
| 03/22/2001 | WO2001020014A1 Modified adenoviral vectors for use in gene therapy |
| 03/22/2001 | WO2001020013A2 Viral replicons and viruses dependent on inducing agents |
| 03/22/2001 | WO2001020012A2 Enhanced plant cell transformation by addition of host genes involved in t-dna integration |
| 03/22/2001 | WO2001020011A1 Dna construct and its use |
| 03/22/2001 | WO2001020010A2 Transcriptionally silenced plant genes |
| 03/22/2001 | WO2001020009A1 Plants having altered amino acid contents and method for the production thereof |
| 03/22/2001 | WO2001020008A2 Vascular-specific promoters |
| 03/22/2001 | WO2001020007A1 A multifunctional system for the efficient manipulation of protein expression in filamentous fungi and method using same |
| 03/22/2001 | WO2001020006A1 Chemically inducible promoter and method for controlling the expression of a target gene in an eukaryote |
| 03/22/2001 | WO2001020005A1 Regulatory sequences and expression cassettes for yeasts, especially for kluyveromyces |
| 03/22/2001 | WO2001020004A2 Protein phosphatase and kinase proteins |
| 03/22/2001 | WO2001020003A2 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof |